Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-AnalysisYaru Zhang, Shan Lin, Junying Xu et al.|Cardiovascular Drugs and Therapy|2021Cited by 27
Cardio-renal protective effect and safety of sodium-glucose cotransporter 2 inhibitors for chronic kidney disease patients with eGFR < 60 mL/min/1.73 m2: a systematic review and meta-analysisYaru Zhang, Nanlan Chen, Junhui Luo et al.|BMC Nephrology|2024Cited by 11